These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8948514)

  • 21. The effect of domperidone on theophylline disposition in the rat.
    Bawazir SA; Al-Hassan MI; Matar KM; Tekle A
    Biopharm Drug Dispos; 1989; 10(6):531-5. PubMed ID: 2611354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia.
    Wójcicki J; Kalinowski W; Gawrońska-Szklarz B
    Arzneimittelforschung; 1985; 35(6):991-3. PubMed ID: 4026928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No influence of single intravenous doses of omeprazole on theophylline elimination kinetics.
    Oosterhuis B; Jonkman JH; Andersson T; Zuiderwijk PB
    J Clin Pharmacol; 1992 May; 32(5):470-5. PubMed ID: 1587966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of theophylline elimination by diltiazem therapy.
    Nafziger AN; May JJ; Bertino JS
    J Clin Pharmacol; 1987 Nov; 27(11):862-5. PubMed ID: 3429693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers.
    Murdoch RD; Zussman B; Schofield JP; Webber DM
    J Clin Pharmacol; 2004 Sep; 44(9):1046-53. PubMed ID: 15317832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hypoalbuminemia on the disposition of theophylline. Comparative study with Sprague-Dawley rats and a mutant Sprague-Dawley hyperlipidemic strain with hypoalbuminemia.
    Nakura H; Tateishi T; Watanabe M; Asoh M; Tanaka M; Kumai T; Kobayashi S
    Drug Metab Dispos; 1998 Jun; 26(6):595-7. PubMed ID: 9616197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.
    DuBois B; Louey S; Giraud GD; Cherala G; Jonker SS
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):226-33. PubMed ID: 25728792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study on bioavailability of theophylline in rabbits as influenced by fatty diet.
    Ashok Kumar S; Chakrabarti A; Garg SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):130-4. PubMed ID: 1791046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers.
    Lin JH; Chremos AN; Chiou R; Yeh KC; Williams R
    Br J Clin Pharmacol; 1987 Nov; 24(5):669-72. PubMed ID: 2893637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of theophylline clearance in gastrointestinal dialysis with charcoal.
    Huang JD
    J Pharm Sci; 1987 Jul; 76(7):525-7. PubMed ID: 3668813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of hyperlipidemia on metabolism, distribution and secretion of lidocaine in patients with primary hyperlipidemia].
    Rózański J
    Ann Acad Med Stetin; 2000; 46():177-87. PubMed ID: 11712303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis].
    Ambroskina VV; Kriachok TA; Larionov OP; Talaieva TV; Bratus' VV
    Fiziol Zh (1994); 2007; 53(6):19-28. PubMed ID: 18309627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemia.
    Wójcicki J; Sulzyc-Bielicka V; Kutrzeba J; Gawrońska-Szklarz B; Droździk M; Sterna Z
    J Clin Pharmacol; 1999 Aug; 39(8):826-33. PubMed ID: 10434235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay methods in a theophylline pharmacokinetic study.
    Lalonde RL; Bottorff MB; Straughn AB
    Ther Drug Monit; 1985; 7(4):442-6. PubMed ID: 3909536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios.
    McNamara PJ; Burgio D; Yoo SD
    Drug Metab Dispos; 1992; 20(2):302-8. PubMed ID: 1352225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children.
    Kumar L; Garg SK; Singh S; Lal R; Shukla VK
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):588-92. PubMed ID: 2613392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH; Sollie FA; Sauter R; Steinijans VW
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem treatment impairs theophylline elimination in patients with bronchospastic airway disease.
    Soto J; Sacristan JA; Alsar MJ
    Ther Drug Monit; 1994 Feb; 16(1):49-52. PubMed ID: 8160255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.